Agenda coming soon!

Great Debates brings together nationally recognized experts in hematologic malignancies to tackle the clinical questions where evidence is unsettled and treatment decisions are genuinely difficult. Rather than one-sided lectures, the program is built around structured debate—pairing experts who disagree and letting you see both sides of the argument play out in real time.

At the 2027 meeting, you can expect the same rigorous, case-based approach that defines this program: head-to-head discussions on frontline and relapsed/refractory treatment strategies across leukemia, lymphoma, myeloma, and CLL, along with the evolving role of novel therapies, sequencing decisions, and how to weigh conflicting data when guidelines fall short.

Sessions are designed to mirror the complexity of actual practice. Faculty stake out opposing positions, defend them with the latest evidence, and work through real patient scenarios so you leave with a clearer framework for your own decision-making, not just a recap of the data.

Join leading experts as they debate the questions that matter most in hematologic oncology—and what the answers mean for your patients.

Stay tuned for the full 2027 agenda.